Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Reiter

Showing results (311-320 of 426) with videos related to

Pageof 43
Sort By:
Cancer Research|November 15, 1995
Allelotype analysis of childhood acute lymphoblastic leukemiaS Takeuchi, C R Bartram, M Wada, et al.
British Journal of Haematology|December 1, 1994
Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropeniasM A Bonilla, D Dale, C Zeidler, et al.
Blood|November 15, 1992
Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM groupA Reiter, M Schrappe, W D Ludwig, et al.
Lancet (London, England)|May 4, 1991
Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reactionJ Maurer, J W Janssen, E Thiel, et al.
Leukemia|June 2, 2006
Loss of heterozygosity on chromosome 6q14-q24 is associated with poor outcome in children and adolescents with T-cell lymphoblastic lymphomaB Burkhardt, J Bruch, M Zimmermann, et al.
Blood|January 11, 2000
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group reportA Reiter, M Schrappe, W D Ludwig, et al.
Klinische Padiatrie|July 1, 1994
[NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 1: Classification and allocation to strategic therapy groups. BIF study group]A Reiter, M Tiemann, W D Ludwig, et al.
Klinische Padiatrie|May 1, 1988
[Significance of procarbazine in the chemotherapy of Hodgkin's disease--a report of the Cooperative Therapy Study DAL-HD-85]G Schellong, I Hörnig, J Brämswig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster GroupK Seidemann, M Tiemann, I Lauterbach, et al.
Microbiology Resource Announcements|July 23, 2025
Draft genome of <i>Conoideocrella luteorostrata</i> ARSEF 14590 (Clavicipitaceae), an entomopathogenic fungus with a wealth of biosynthetic and biocontrol potentialBrian Lovett, Jason E Stajich, Hana Barrett, et al.
Pageof 43

Showing results (311-320 of 426) with videos related to

Sort By:
Pageof 43
Cancer Research|November 15, 1995
Allelotype analysis of childhood acute lymphoblastic leukemiaS Takeuchi, C R Bartram, M Wada, et al.
British Journal of Haematology|December 1, 1994
Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropeniasM A Bonilla, D Dale, C Zeidler, et al.
Blood|November 15, 1992
Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM groupA Reiter, M Schrappe, W D Ludwig, et al.
Lancet (London, England)|May 4, 1991
Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reactionJ Maurer, J W Janssen, E Thiel, et al.
Leukemia|June 2, 2006
Loss of heterozygosity on chromosome 6q14-q24 is associated with poor outcome in children and adolescents with T-cell lymphoblastic lymphomaB Burkhardt, J Bruch, M Zimmermann, et al.
Blood|January 11, 2000
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group reportA Reiter, M Schrappe, W D Ludwig, et al.
Klinische Padiatrie|July 1, 1994
[NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 1: Classification and allocation to strategic therapy groups. BIF study group]A Reiter, M Tiemann, W D Ludwig, et al.
Klinische Padiatrie|May 1, 1988
[Significance of procarbazine in the chemotherapy of Hodgkin's disease--a report of the Cooperative Therapy Study DAL-HD-85]G Schellong, I Hörnig, J Brämswig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster GroupK Seidemann, M Tiemann, I Lauterbach, et al.
Microbiology Resource Announcements|July 23, 2025
Draft genome of <i>Conoideocrella luteorostrata</i> ARSEF 14590 (Clavicipitaceae), an entomopathogenic fungus with a wealth of biosynthetic and biocontrol potentialBrian Lovett, Jason E Stajich, Hana Barrett, et al.
Pageof 43